BJA Advance Access originally published online on June 5, 2009
British Journal of Anaesthesia 2009 103(1):89-98; doi:10.1093/bja/aep141
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anaesthesia and myocardial ischaemia/reperfusion injury
Departement of Anesthesiology, AMC—University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands
* Corresponding author. E-mail: j.frassdorf{at}amc.uva.nl
Anaesthetists are confronted on a daily basis with patients with coronary artery disease, myocardial ischaemia, or both during the perioperative period. Therefore, prevention and ultimately adequate therapy of perioperative myocardial ischaemia and its consequences are the major challenges in current anaesthetic practice. This review will focus on the translation of the laboratory evidence of anaesthetic-induced cardioprotection into daily clinical practice.
Keywords: anaesthetics i.v., propofol; anaesthetics volatile; heart, ischaemia; muscle cardiac
Read all E-letters![]()
CiteULike
Connotea
Del.icio.us What's this?
E-letters: